Ulcerative colitis increases 11-fold in Victorian children 2 May 2012 0 comments Researchers claim to have found the largest increase of ulcerative colitis ever reported in a population – and it is in Victorian children.
Glucose, not insulin, linked to colorectal cancer risk 25 Jan 2012 0 comments An analysis from the Women's Health Initiative has suggested that colorectal cancer risk is associated with elevated fasting glucose levels, but not with hyperinsulinaemia.
Infliximab supported in moderate to severe ulcerative colitis 18 Jan 2012 0 comments Biological therapy has the potential to change the course of ulcerative colitis and achieve treatment goals beyond the relief of symptoms, an international consensus group has concluded.
Little advantage from stenting malignant colonic obstruction: Cochrane 23 Nov 2011 0 comments Colorectal stenting is an inherently appealing strategy to relieve acute obstructions in patients with colorectal cancer but is less successful than emergency surgery, a Cochrane review has concluded.
Little advantage from stenting: Cochrane 16 Nov 2011 0 comments Stenting is an appealing strategy to relieve acute obstructions in patients with CRC but is less successful than surgery.
TNF inhibitors may not raise serious infection risk 9 Nov 2011 0 comments Controversial new research suggests TNF inhibitors do not raise the risk of serious infections more than non-biologic treatments.
IBD ''an emerging global disease'' 2 Nov 2011 0 comments The prevalence of IBD in increasing throughout the world, indicating its emergence as a global disease, a review concludes.
NAFLD death rate similar to hep C 5 Oct 2011 0 comments NAFLD is associated with similar mortality as hepatitis C virus infection, Australian and international researchers have found.
Fee-for-service medicine: productivity vs quality? 8 Sep 2011 0 comments A debate in the Medical Journal of Australia has addressed the merits of salaried positions compared to fee-for-service medicine.
New genetic markers promising as a guide to HCV therapy 31 Aug 2011 0 comments Two newly discovered genes have considerable promise as predictors of patients’ response to pegylated interferon and ribavirin.